For first time in history, U.S. will treat Ebola patients - KYTX CBS 19 Tyler Longview News Weather Sports

For first time in history, U.S. will treat Ebola patients

Posted: Updated:

(WFAA) - For the first time in history, a patient with Ebola will be treated in the United States.

There has never been a case of the deadly virus in America, but that's changing as two infected Americans will soon fly home for treatment.

This trip is raising a lot of questions. How will the Ebola patients be flown back to the United States safely without infecting others?

This is the answer: A government-owned jet outfitted with a portable isolation ward.

It's designed by the CDC and the Department of Defense and can house sick patients for several hours, along with medical personnel.

Dr. Kent Brantly and Nancy Writebol, who are currently in grave, but stable condition in Liberia, are likely heading to a special wing of Emory University Hospital in Atlanta.

In Dallas, the director of Medical Emergency Services says as scary as Ebola is, the risk of getting infected here at home is low.

"So just a few years ago [they] actually set up this specialized isolation ward, actually separate from the rest of the hospital for this very purpose. In case there’s some kind of really bad kinda virus or some of contagious thing that comes out, the person can be repatriated, as we say, back to the United States," Dr. Paul Pepe told News 8.

There is no known cure for Ebola. There's an experimental vaccine, but testing isn't expected until at least September.

The CDC meanwhile has issued a travel warning for Americans wanting to fly to Liberia, Guinea and Sierra Leone.

Additional doctors are flying to Africa from the CDC to fight the outbreak.

Powered by WorldNow

CBS19, MYTX & KCEB
2211 ESE Loop 323
Tyler, TX 75701
Phone (903) 581-2211
Fax (903) 581-5769

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KYTX. All Rights Reserved. Users of this site agree to the Terms of Service, Privacy Notice/Your California Privacy Rights, and Ad Choices.